Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cancer of Prostate

fluorodeoxyglucose f18 has been researched along with Cancer of Prostate in 337 studies

Research

Studies (337)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (4.45)	18.2507
2000's	87 (25.82)	29.6817
2010's	173 (51.34)	24.3611
2020's	62 (18.40)	2.80

Authors

Authors	Studies
Bauckneht, M; D'Amico, F; Donegani, MI; Miceli, A; Mora, M; Morbelli, S; Piol, N; Riondato, M; Spina, B	1
Demir, H; Hekimsoy, T; Isgoren, S; Koroglu, E	1
Gan, H; Hu, X; Liu, C; Liu, W; Pan, J; Song, S; Wang, B; Wei, Y; Wu, J; Ye, D; Zhang, T; Zhao, J; Zhu, B; Zhu, Y	1
Chen, X; Fan, Y; Li, Q; Tong, Z; Zhang, J	1
Lin, R; Sun, Z; Tian, A; Yu, J; Yuan, X; Zhang, F; Zheng, Q; Zhong, Z	1
Dong, A; Zhao, B; Zuo, C	1
Dong, A; Qiu, S; Zhu, Y; Zuo, C	1
Fanti, S; Farolfi, A; Mei, R; Morigi, JJ	1
Guler, OC; Onal, C	1
Dong, A; Ji, X	1
Gao, M; Lu, Y	1
Ah-Thiane, L; Ferrer, L; Fleury, V; Le Thiec, M; Maucherat, B; Rousseau, C; Rusu, D	1
Pan, J; Wang, B; Zhu, Y	1
Dong, A; Zhu, Y; Zuo, C	1
Hirata, K; Kitajima, K; Nakajo, M; Nakamoto, Y; Toriihara, A	1
Ahmadsei, M; Andratschke, N; Badra, EV; Christ, SM; Guckenberger, M; Heesen, P; Huellner, M; Kroeze, SGC; Kühnis, A; Mayinger, M; Muehlematter, UJ; Pohl, K; Willmann, J	1
Chen, H; Meng, T; Pang, Y; Shang, Q; Xu, W	1
Huang, D; Huang, Z; Liu, Y; Yang, X	1
Gavane, S; Hasanovic, A; Trak, J	1
Abikhzer, G; Bénard, F; Black, P; Burrell, S; Cossette, M; Eigl, BJ; Harsini, S; Krauze, A; Mar, C; Martin, M; Metser, U; Nichol, A; Romsa, J; Saad, F; Soucy, JP; Tardif, JC; Turcotte, E; Wilson, D; Zukotynski, K	1
Choyke, PL; Chung, JY; Escorcia, FE; Hernandez, J; Jakhete, N; Jones, J; Kassin, M; Lindenberg, L; Maass-Moreno, R; Mena, E; Molitoris, JK; Monge, C; Rabiee, A; Saboury, B; Salerno, KE; Shih, J; Turkbey, B; Unger, KR; Wood, B	1
Alabed, YZ	1
Kökkülünk, HT; Yildirim, AK	1
Adediran, OA; Bhave, MA; Crowe, RJ; Fielder, B; Friend, S; Graham, C; Holbrook, A; Kalinsky, K; Lawal, IO; Meisel, J; Muzahir, S; Schuster, DM; Styblo, TM; Torres, MA; Ulaner, GA	1
Barboro, P; Bauckneht, M; Bruno, S; Campi, C; Carta, S; Chiesa, S; Chiola, S; Cossu, V; D'Amico, F; Fornarini, G; Marini, C; Miceli, A; Morbelli, S; Orengo, AM; Piana, M; Riondato, M; Sambuceti, G; Signori, A; Terrone, C; Vitale, F	1
Aksoy, M; Demirkol, MO; Esen, B; Kabaoglu, ZU; Kordan, Y; Kulac, I; Seymen, H	1
Huang, S; Lin, Z; Wu, S; Yin, L; Yu, L; Yue, J	1
Arslan, E; Baloğlu, MC; Çermik, TF; Ergül, N; Tatar, G	1
Ecsedi, B; Grahovac, M; Hacker, M; Haug, A; Kluge, K; Krajnc, D; Li, X; Papp, L; Rasul, S; Spielvogel, CP; Traub-Weidinger, T; Zhao, M	1
Akbas, S; Arslan, E; Battal Havare, S; Beyhan, E; Can Trabulus, FD; Cin, M; Ergül, N; Erol Fenercioglu, Ö; Fikret Çermik, T; Mermut, Ö; Sahin, R	1
Bai, Y; Dong, A; Lin, X; Xu, S; Yang, B	1
Cohen, D; Even-Sapir, E; Fahoum, I; Hazut Krauthammer, S; Kesler, M	1
Cai, J; Chen, H; Meng, T; Pang, Y; Xu, W	1
Asher, CR; Khanna-Neicheril, R; Lopez, D; Sanchez-Nadales, A	1
Basu, S; Chakraborty, S; Chakravarty, R; Kalshetty, A; Nazar, AK	1
Basu, S; Chalikandy, A; Yadav, S	1
Chekuri, S; Doroudinia, A	1
Arora, G; Bhalla, AS; Kakkar, A; Kumar, D; Kumar, N; Pathak, A; Shamim, SA; Sikka, K; Singh, CA; Thakkar, A	1
Kasibhatla, MS; Koontz, BF	1
Burger, IA; Ghafoor, S; Vargas, AH	1
Mountz, JM; Muthukrishnan, A; Nguyen, NC	1
George, T; Joshi, PV; Joshi, S; Kulkarni, M; Sahasrabudhe, S; Shewalkar, B	1
Ahmadzadehfar, H; Bakht, MK; Cheon, GJ; Chiaramonte, J; Coleman, IM; Derecichei, I; Dong, X; Ferraiuolo, RM; Fifield, BA; Jeong, CW; Kang, KW; Kwak, C; Lovnicki, JM; Lubanska, D; Morrissey, C; Oh, SW; Porter, LA; Reynolds, MR; Stringer, KF; Trant, JF; Tubman, J; Wang, Y	1
Alavi, A; Høilund-Carlsen, PF	1
Baratto, L; Iagaru, A; Minamimoto, R; Sonni, I	1
Acevedo Báñez, I; Fernández-Rodríguez, P; Jiménez-Hoyuela García, JM; Martín-Marcuartu, JJ; Masero Carretero, JM	1
Dede, DS; Gumuskaya, B; Yildirim, N	1
Demir, H; Gorur, GD; Hekimsoy, T; Isgoren, S; Uslu, H	1
Bohn, P; Damilleville-Martin, M; Decazes, P; Modzelewski, R; Thureau, S; Vera, P	1
Cho, SY; Jadvar, H; Kim, CK; Potvin, K; Winquist, E; Zukotynski, KA	1
Boerman, OC; Breukels, V; Franssen, GM; Heerschap, A; Heskamp, S; Jansen, KCFJ; Schalken, JA; Scheenen, TWJ; van Heijster, FHA; Veltien, A	1
Ahn, H; Berndt, M; Bullich, S; Chae, SY; Cho, YM; Gambhir, SS; Kim, HO; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Na, SJ; Park, SY; Stephens, AW; Wardak, M	1
Fanti, S; Farolfi, A; Koschel, S; Murphy, DG	1
Das, CJ; Kumar, R; Kumar, S; Patel, C; Raju, S; Sahoo, R; Sharma, A	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Kamai, T; Kijima, T; Owada, A; Suzuki, I	1
Barentsz, JO; Gotthardt, M; Israël, B; Janssen, MJR; Mehra, N; Mulders, PFA; Muselaers, CHJ; Nagarajah, J; Privé, BM; Schilham, MGM; Sedelaar, M; van Oort, IM; Verzijlbergen, F; Witjes, JA; Zámecnik, P	1
Alfredo, B; Antonella, C; Fabio, M; Sergio, B; Stefano, P	1
Aslani, A; Bailey, DL; Eslick, EM; Gholami, YH; Hioki, T; Howell, VM; Marquis, H; McKelvey, KJ; Willowson, KP	1
Ben Shimol, J; Davidson, T; Domachevsky, L; Dotan, Z; Fridman, E; Giladi, Y; Leibowitz, R; Rosenzweig, B	1
Behr, SC; Calais, J; Eiber, M; Emmett, L; Fendler, WP; Hofman, MS; Hope, TA; Lawhn-Heath, C; Rowe, SP; Salavati, A	1
McClenathan, M; Peacock, JG	1
Gu, J; Lu, Y; Xu, G	1
McEwan, LM; Wong, D; Yaxley, J	1
De Clermont-Gallerande, H; Fernandez, P; Meyer, M; Schollhammer, R	1
Goldberg, H; Hamilton, RJ	1
Eiber, M; Fendler, W; Herrmann, K; Lütje, S; Slavik, R	1
Chen, HM; Chiu, H; Chung, YH; Lin, G; Lin, YC; Lu, KY; Tsai, CK; Wang, CC; Yen, TC	1
Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D	1
Bal, C; Datta Gupta, S; Kumar, R; Parida, GK; Shamim, SA; Singhal, A; Tripathy, S	1
Beauregard, JM; Bergeron, M; Blouin, AC; Buteau, FA; Duchesnay, N; Dujardin, T; Fradet, V; Fradet, Y; Lacombe, L; Lavallée, E; Makao-Nguile, M; Pouliot, F; Tiguert, R	1
Allkemper, T; Auf der Springe, K; Huss, S; Noto, B; Stegger, L	1
Bronsert, P; Reichel, K; Ruf, J	1
Cholewinski, W; Czepczynski, R; Pietrzak, AK; Wierzchoslawska, E	1
Alam, IS; Beinat, C; Chen, YS; Gambhir, SS; Haywood, T; Murty, S; Patel, CB	1
Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S	1
Eiber, M; Gschwend, JE; Horn, T; Maurer, T; Rauscher, I; Weber, WA	1
Fraum, TJ; Hope, TA; Ippolito, JE; Kim, EH; Ludwig, DR; Schroeder, P	1
Basu, S; Parghane, R	1
Afshar-Oromieh, A; Ahmadzadehfar, H; Essler, M; Rahbar, K	1
De Leiris, N; Djaileb, L; Leenhardt, J; Riou, L; Vuillez, JP	1
Acar, E; Kaya, GÇ	1
Balasse, L; Bouhlel, A; Ding, L; Fernandez, S; Garrigue, P; Giorgio, S; Guillet, B; Huang, Y; Iovanna, J; Lan, W; Laurini, E; Liu, X; Lyu, Z; Marson, D; Mas, E; Peng, L; Pricl, S; Tang, J; Tintaru, A; Weng, Y; Zhang, M	1
Ding, C; Lai, R	1
Behr, SC; Flavell, RR; Hope, TA; Perez, PM; Small, EJ; van Zante, A	1
Gerke, O; Høilund-Carlsen, PF; Lund, L; Mortensen, MA; Poulsen, MH; Vilstrup, MH	1
Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S	1
Baranski, AC; Bruchertseifer, F; Dimitrakopoulou-Strauss, A; Kopka, K; Kratochwil, C; Mier, W; Morgenstern, A; Muehlbauer, KR; Neels, O; Schmeiser, HH; Schmezer, P	1
Bosco, A; Dhiantravan, N; Hovey, E; Wegner, EA	1
Jadvar, H	8
Andersen, KF; Divilov, V; Koziorowski, J; Lewis, JS; Pillarsetty, N	1
Amrami, KK; Babu, MA; Dyck, PJ; Howe, BM; Kawashima, A; Nathan, MA; Spinner, RJ	1
Keshari, KR; Kurhanewicz, J; Sai, V; Vanbrocklin, HF; Wang, ZJ; Wilson, DM	1
Andreou, A; Fisher, C; MacVicar, D; Sohaib, A; Whitten, C	1
Conti, PS; Desai, B; Dorff, TB; Groshen, SG; Jadvar, H; Ji, L; Pinski, JK; Quinn, DI	1
Dong, A; Lu, J; Wang, Y; Zuo, C	2
Kitajima, K; Murphy, RC; Nathan, MA; Sugimura, K	1
Goodman, MM; Kawai, K; Oka, S; Okudaira, H; Ono, M; Schuster, DM; Shirakami, Y	1
Han, JK; Pan, B; Wang, SC; Xu, A	1
Ouvrier, MJ; Thariat, J; Vignot, S	1
Bolton, D; Chan, JG; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Tochon-Danguy, H; Wada, M	1
Dong, A; Gong, J; Wang, Y; Zuo, C	1
Borbély, K; Géczi, L; Kásler, M	1
Andersen, KF; Divilov, V; Koziorowski, J; Lewis, JS; Pillarsetty, N; Sevak, K	1
Fox, JJ; Goldman, DA; Gonen, M; Hricak, H; Kuk, D; Larson, SM; Morris, MJ; Scher, HI; Vargas, HA; Wassberg, C; Wibmer, A	1
Kijima, H; Miura, H; Morohashi, S; Ono, S; Seino, H; Takai, Y; Tsushima, F; Wu, Y	1
Bailly, M; Besse, H; Gauvain, S; Kerdraon, R; Metrard, G	1
Coleman, RE; Duan, F; Hanna, L; Hillner, BE; Shields, AF; Siegel, BA	1
Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A	1
Bai, Y; Dong, A; Lu, J; Wang, Y; Zuo, C	1
Eiber, M; Krause, BJ; Maurer, T	1
Siegel, C	1
Buck, AK; Donat, U; Israel, I; Richter, D; Samnick, S; Stritzker, J; van Ooschot, M	1
Fuccio, C; Ivaldi, GB; Mensi, M; Palumbo, R; Rubino, B; Scopesi, L; Spinapolice, EG; Trifirò, G	1
Doran, MG; Fareedy, SB; Gavane, S; Osborne, JR; Spratt, DE; Tarlinton, L; Zelefsky, MJ	1
Beck, T; Grosu, AL; Jilg, CA; Meyer, PT; Rischke, HC; Schultze-Seemann, W; Vach, W; Wieser, G	1
Dong, A; Gong, J; Lu, J; Wang, Y; Yang, J; Zhang, H; Zuo, C	1
Bhatnagar, A; Fisher, PB; Gabrielson, K; Gabrielson, M; Green, G; Mease, RC; Minn, I; Pomper, MG; Sarkar, S; Simmons, B; Sysa, P; Wang, Y	1
Bertagna, F; Giovanella, L; Sadeghi, R; Treglia, G	1
Brunotte, F; Cochet, A; Cormier, L; Créhange, G; Humbert, O; Kanoun, S; Walker, PM	1
Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R	1
Bae, SK; Kang, DI; Kang, PM; Kim, W; Kwak, HS; Lee, SS; Min, K; Seo, WI	1
Berndorff, D; Chang, E; Cheng, Z; Ellinghaus, P; Gambhir, SS; Gekeler, V; Liu, H; Liu, S; Unterschemmann, K	1
Calais, J; Castier, Y; De Kerviler, E; Lussato, D; Menard, J; Merlet, P; Mongiat-Artus, P	1
Bijnsdorp, IV; Geldof, AA; Hoekstra, OS; Oprea-Lager, DE; van de Ven, PM; van den Eertwegh, AJ; van Kanten, MP; van Moorselaar, RJ	1
Agarwal, R; Boyle, KE; Cramer, SD; Deep, G; Eckel, RH; Glodé, LM; Hitz, CA; Lucia, SM; Maroni, P; Pac, CT; Schlaepfer, IR; Serkova, NJ	1
Bergman, CN; Krieger, S; Richter, S; Rogers, BE; Way, JD; Wuest, F; Wuest, M	1
Duan, F; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA	1
Bartlett, RM; Ding, YS; Friedman, K; Koesters, T; Logan, J; Rosenkrantz, AB; Taneja, SS; Vahle, AK	1
Borbély, K	1
Berczi, C; Farkas, B; Flaskó, T; Galuska, L; Garai, I; Oszlánszki, A	1
Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T	1
Aronen, HJ; Auren, J; Huovinen, R; Jambor, I; Kajander, S; Kauppila, E; Kemppainen, J; Kuisma, A; Merisaari, H; Minn, H; Noponen, T; Ramadan, S; Sandell, M; Saunavaara, J; Seppänen, M	1
Bolton, D; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Wada, M	1
Ahn, H; Hong, JH; Jeong, IG; Kim, CS; Kwon, T; You, D	1
Beauregard, JM; Blouin, AC; Bouchard, F; Caron, A; Dujardin, T; Fradet, V; Fradet, Y; Lacombe, L; Lemay, C; Pouliot, F; Rimac, G; Tiguert, R	1
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G	1
Balata, H; Evison, M; O'Donnell, P	1
Calais, J; Lussato, D; Merlet, P	1
Colombié, M; Goineau, A; Rousseau, C; Sadot-Lebouvier, S; Supiot, S	1
Banzo, I; Carril, JM; Jiménez-Bonilla, J; Martínez-Rodríguez, I; Quirce, R	1
Hess, S; Høilund-Carlsen, PF; Lund, L; Petersen, H; Poulsen, MH	1
Bivalacqua, TJ; Blackford, A; Carter, HB; Cho, SY; Cornish, TC; Dannals, RF; Faraj, SF; Gage, KL; Gonzalez-Roibon, N; Guner, G; Han, M; Holt, D; Lodge, MA; Macura, KJ; Mease, RC; Munari, E; Netto, GJ; Partin, AW; Pavlovich, CP; Pomper, MG; Rowe, SP	1
Bertagna, F; Bertoli, M; Biasiotto, G; Bosio, G; Dib, B; Fracassi, F; Giovanella, L; Giubbini, R; Piccardo, A; Treglia, G	1
Brown, AM; Choyke, PL; Johnson, LM; Kurdziel, KA; Lindenberg, ML; Merino, MJ; Pinto, PA; Pruthy, S; Sankineni, S; Shih, JH; Turkbey, B; Wood, BJ	1
Liu, Y; Xu, B	1
Hsieh, TC; Kao, CH; Lin, CC; Sun, SS; Wu, YC	1
Barkhodari, A; Gambhir, SS; Iagaru, A; Jackson, T; Jamali, M; Loening, A; Minamimoto, R; Mosci, C; Obara, P; Taviani, V; Vasanawala, S	1
Duan, Z; Jiao, G; Lei, J; Ouyang, Q	1
Cheng, A; Liping, F; Wang, X; Yang, J; Zhao, L	1
He, Q; Luo, G; Shi, X; Yi, C; Yu, D; Zhang, X	1
Bex, A; De Jong, J; Fransen van de Putte, EE; Horenblas, S; Meijer, RP; Mertens, LS; Reesink, DJ; van der Poel, HG; van Rhijn, BW; van Werkhoven, E; Vegt, E	1
Fei, X; Hu, J; Lei, H; Li, B; Liang, S; Qin, D; Wang, Y; Wu, Y; Xu, H	1
Aide, N; Allouache, N; Dugué, AE; How Kit, N; Joly, F; Lesaunier, F; Sevin, E	1
Hsiao, PC; Kao, PF; Kao, YL; Weng, JH	1
Aguiar, P; Domínguez-Prado, I; Pardo-Montero, J; Ruibal, Á; Silva-Rodríguez, J; Tsoumpas, C	1
Araujo, JC; Erwin, WD; Etchebehere, EC; Fox, P; Macapinlac, HA; Milton, DR; Rohren, EM; Swanston, NM; Wendt, RE	1
Chao, IM; Chen, ML; Hsieh, PJ; Hsieh, TS; Su, HY	1
Evangelista, L; Pasquale, R	1
Goineau, A; Supiot, S	1
Chin, BB; Oldan, JD	1
Asa, S; Gungor, S; Kupik, O	1
Bristow, RG; Chen, J; Cui, L; Jin, CS; Overchuk, M; Wilson, BC; Zheng, G	1
Krause, BJ; Schiemann, M; Schwarz, T; Seidl, C; Senekowitsch-Schmidtke, R	1
Bastos, D; Cerri, G; Etchebehere, E; Queiroz, MA; Santos, A; Viana, P	1
Kajiwara, M; Moriyama, H; Yonehara, S	1
Arimoto, MK; Higashi, T; Ishitoya, S; Kagawa, S; Kishibe, Y; Nakamoto, Y; Nishii, R; Oonishi, H; Takahashi, M; Togashi, K; Yamauchi, H	1
Chen, Z; Guo, G; Liu, J; Liu, L; Wang, D; Wang, T; Zhao, L	1
Bui, C; Do, V; Hadjashrafi, A; Loh, H; Mansberg, R; Shetty, D	1
Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A	1
Joy, A; Madhavan, J; Pillai, MR; Raman, V; Sasikumar, A; Vasudevan, A	1
Gianolli, L; Incerti, E; Mapelli, P; Picchio, M	1
Fanti, S; Nanni, C; Schuster, DM	1
Cavaliere, C; D'Aniello, C; Facchini, G; Fiorica, F	1
Beaulieu, A; Beauregard, JM	1
Feuerecker, B; Glaser, SJ; Gómez, PA; Hundshammer, C; Kubala, E; Menzel, MI; Muñoz-Álvarez, KA; Pariani, G; Schilling, F; Schulte, RF; Schwaiger, M; Topping, G	1
Baratto, L; Iagaru, A; Sonni, I	1
Liu, Y	2
Araya, T; Fujimura, M; Ishiguro, T; Kasahara, K; Katayama, N; Kimura, H; Minato, H; Yasui, M	1
Chatziioannou, AF; Dougall, WC; Kang, CO; Lieberman, JR; Liu, NQ; Petrigliano, FA; Stout, D; Virk, MS	1
Obando, JA; Samii, JM; Yasrebi, M	1
Arzumanov, AA; Karelin, MI; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS	1
Bertaccini, A; Borghesi, M; Brunocilla, E; Castellucci, P; Concetti, S; Fanti, S; Farsad, M; Franceschelli, A; Franchi, R; Garofalo, M; Manferrari, F; Martorana, G; Nanni, C; Rocca, C; Sanguedolce, F; Schiavina, R	1
Belloli, S; Bellone, M; Fazio, F; Freschi, M; Hess Michelini, R; Jachetti, E; Lecchi, M; Moresco, RM; Picchio, M; Valtorta, S	1
Absher, K; Conrad, GR; Lee, J; Sinha, P	1
Emonds, KM; Mortelmans, L; Mottaghy, FM; Swinnen, JV	1
Feins, R; Funkhouser, WK; Khandani, AH; Socinski, MA	1
Inoue, T; Kubota, Y; Minamimoto, R; Tateishi, U; Uemira, H; Yamanaka, S	1
García-Velloso, MJ; Garrastachu, P; Martí-Climent, J; Peñuelas, I; Quincoces, G; Richter, JA; Rioja, J; Rodríguez, M; Zudaire, J	1
Celen, Z; Karakok, M; Sevinc, A; Yilmaz, M	1
Hakenberg, OW; Protzel, C	1
Cook, G; deSouza, NM; Messiou, C	1
Berián Polo, JM; Martínez-Monge, R; Richter, JA; Rincón Mayans, A; Rioja Zuazu, J; Rodríguez, M; Sansi, AS; Zudaire Bergera, JJ	1
Cigarral, C; de la Torre, A; Montero, A; Rodríguez, G; Salas, C	1
Lupo, R; Merino, B; Monet, A	1
Farghaly, HR; Mekkawy, MA; Mostafa, MS; Nguyen, NC; Osman, MM; Sayed, MH	1
Hsiung, CY; Huang, ML; Hung, GU; Lin, ST	1
Anand, A; Dzik-Jurasz, A; Hu, J; Rathkopf, D; Ross, RW; Scher, HI; Tanaka, E; Wong, BY; Woo, MM; Yang, W	1
Ghesani, NV; Liu, Y; Zuckier, LS	1
Avril, N; Dambha, F; Murray, I; Powles, T; Sahdev, A; Shamash, J	1
Azuma, H; Ibuki, N; Inamoto, T; Katsuoka, Y; Komura, K; Koyama, K; Tsuji, M; Ubai, T	1
Bae, KT; Goshima, S; Hoshi, H; Kako, N; Kanematsu, M; Kondo, H; Watanabe, H; Yamada, T; Yamamoto, N	1
Hodgson, R; Huang, YT; Ravi Kumar, AS; Steinke, K	1
Chassagne-Clément, C; Cimarelli, S; Heudel, PE; Janody, P; Lachenal, F; Ricard, F; Sebban, C	1
Campos, GC; de Carvalho Flamini, R; de Gusmão Funari, MB; Livorsi da Cunha, M; Mello, ME; Osawa, A; Wagner, J; Yamaga, L	1
Arnott, J; Hahn, NM; Hammers, H; Harrison, MR; Kim, K; Liu, G; Oh, WK; Perlman, S; Pili, R; Sidor, C; Sweeney, C; Wilding, G	1
Beauregard, JM; Degrado, TR; Hicks, RJ; Roselt, P; Williams, SG	1
Jung, SA; Kim, CG; Kim, DW; Park, SA	1
Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L	1
Inoue, T; Kubota, Y; Minamimoto, R; Nagashima, Y; Sano, F; Shizukuishi, K; Tateishi, U; Terao, H; Uemura, H; Yamanaka, S	1
Moule, RN; Nunan, T; Wong, WL	1
Choi, WH; Chung, SK; H O, J; Han, EJ; Yoo, IR	1
Fox, JJ; Gönen, M; Humm, J; Larson, SM; Meirelles, GS; Morris, MJ; Ravizzini, GC; Scher, HI; Schöder, H	1
Schönberg, S	1
Alaee, F; Chatziioannou, AF; Dougall, WC; Lieberman, JR; Petrigliano, FA; Stout, D; Sugiyama, O; Virk, MS	1
Aerts, J; Giacomelli, F; Grayet, B; Hustinx, R; Jerusalem, G; Mella, C; Mievis, F; Rorive, A; Tancredi, T; Waltregny, D; Withofs, N	1
Brower, V	1
Kim, J; Visioni, A	1
Eary, JF; Hackenbracht, JA; Higano, CS; Link, JM; Mankoff, DA; Montgomery, RB; Muzi, M; Rezvani, BB; Yu, EY	1
Aschoff, P; Pfannenberg, C; Reimold, M; Werner, MK	1
Andreopoulos, D; Frangos, S; Giannopoulou, E; Lutz, S; Tselis, N; Vassiliou, V	1
Bolton, D; Chang, JH; Clouston, D; Davis, ID; Gong, SJ; Hamilton, CS; Joon, DL; Khoo, V; Lee, ST; Scott, AM	1
Fukui, I; Hayasaka, K; Koyama, M	1
Brennan, C; Campos, C; Graeber, TG; Heguy, A; Huse, JT; Kastenhuber, ER; Komisopoulou, E; Larson, SM; Linkov, I; Mellinghoff, IK; Osborne, JR; Palaskas, N; Phelps, ME; Plaisier, SB; Port, E; Rohle, D; Sander, C; Schultz, N; Taschereau, R; Tran, C; Wong, J; Wu, H; Yannuzzi, N	1
Emonds, KM; Mortelmans, L; Mottaghy, FM; Nuyts, J; Swinnen, JV; van Weerden, WM; Vanderhoydonc, F	1
Calaminus, C; Duchamp, O; Honndorf, VS; Judenhofer, MS; Kukuk, D; Machulla, HJ; Pichler, BJ; Quintanilla-Martinez, L; Raguin, O; Reischl, G; Schönberger, T; Wiehr, S	1
Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yen, KY	1
Desai, B; Elatre, W; Jadvar, H; Quinn, DI	1
Bomanji, J; Hashemi, M; Iordanidou, L; Markar, SR; Mitchell, I; Read, S; Stoker, D; Vyas, S; Winslet, M	1
Autran-Blanc, E; Fox, JJ; Gavane, S; Gönen, M; Humm, JL; Larson, SM; Morris, MJ; Nehmeh, S; Scher, HI; Schöder, H; Van Nuffel, A	1
Ishihara, K; Kimura, G; Kondo, Y; Kumita, S; Kuwako, T; Sato, H; Shiiba, M; Tsuchiya, S; Yoshihara, H; Yoshihara, N	1
Bartenstein, P; Cumming, P; Graute, V; Hacker, M; Hartenbach, M; Jansen, N; Klanke, K; Scherr, MK; Seitz, M; Thieme, S; Tiling, R; Ubleis, C	1
Oyama, N; Yokoyama, O	1
Aboagye, EO; Alam, IS; Awais, RO; Brickute, D; Carroll, L; Nguyen, QD; Smith, G; Tomasi, G; Turton, DR; Twyman, FJ; Witney, TH	1
Anak, Ö; Baselga, J; Birle, D; Chen, LC; Hackl, W; Krop, I; Markman, B; Melendez Cuero, M; Mita, M; Shapiro, GI; Siu, L; Stutvoet, S; Tabernero, J	1
Fair, JR; Golden, MJ	1
Bjartell, A; Evans-Axelsson, S; Hagman, Z; Lilja, H; Nilsson, O; Olsson, T; Örbom, A; Peterson, P; Strand, J; Strand, SE; Tolmachev, V; Ulmert, D; Wennerberg, J; Wingårdh, K	1
Han, A; Hu, M; Wang, X; Xue, J; Zheng, J	1
Conti, PS; Desai, B; Dorff, TB; Groshen, SG; Gross, ME; Jadvar, H; Ji, L; Pinski, JK; Quinn, DI	1
Beets-Tan, RG; Groenendaal, G; Houweling, AC; Lambin, P; van der Heide, UA	1
Buchegger, F; Chouiter, A; Dipasquale, G; Miralbell, R; Namy, S; Ratib, O; Steiner, C; Vees, H; Velazquez, M; Zilli, T	1
Chong, A; Hwang, EC; Hwang, I; Jung, SI; Kang, TW; Kim, SO; Kwon, DD; Park, K; Ryu, SB	1
Ahlström, H; Johansson, S; Mosavi, F; Sandberg, DT; Sörensen, J; Turesson, I	1
Abolmaali, N; Froehner, M; Wirth, MP	1
Bal, C; Bandopadhyaya, GP; Damle, NA; Kumar, L; Kumar, P; Lata, S; Malhotra, A	1
Bombardieri, E; Crippa, F; Pauwels, EK; Stokkel, MP; Ugrinska, A	1
Biersack, HJ; Matthies, A; Reinhardt, MJ	1
Akhurst, T; Etchebehere, EC; Gonen, M; Humm, K; Larson, SM; Macapinlac, HA; Scher, HI; Yeung, HW	1
De Cobelli, F; Fazio, F; Gianolli, L; Landoni, C; Maschio, AD; Matarrese, M; Messa, C; Picchio, M	1
Belldegrun, AS; Berger, F; Gambhir, SS; Matherly, J; Nguyen, D; Pantuck, AJ; Tso, CL; Zisman, A	1
Binns, D; Frydenberg, M; Hicks, R; Hogg, A; Salminen, E	1
Engelbach, JA; Jones, LA; Kim, J; Mercer, NM; Oyama, N; Sharp, TL; Welch, MJ	1
Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W	1
Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J	1
Brioschi, M; De Cobelli, F; Del Maschio, A; Fazio, F; Gianolli, L; Landoni, C; Matarrese, M; Matei, DV; Messa, C; Picchio, M; Rigatti, P; Rocco, F; Sironi, S	1
Andriole, GL; Dehdashti, F; Fischer, KC; Kibel, AS; Michalski, JM; Miller, TR; Oyama, N; Picus, J; Siegel, BA; Welch, MJ	1
Bourguet, P	1
Chang, CH; Changlai, SP; Kao, A; Shen, YY; Tsai, JJ; Wu, HC	1
Cook, GJ; Husband, JE; Koh, DM	1
Espiritu, JI; Segall, GM; Sung, J; Terris, MK	1
Delbeke, D; Hopper, OW; Kikkawa, R; Ludwig, V; Martin, WH	1
Ahmad, N; Keehn, CA; Seigne, J; Szabunio, M; Wade, M	1
Kransdorf, MJ; O'Connor, MI; Peterson, JJ	1
Garcia, JR; Lomeña, F; Lopez, S; Perez, G; Setoain, X; Simo, M; Soler, M	1
Akhurst, TA; Beattie, B; Bornmann, W; Dyke, J; Erdi, Y; Finn, RD; Gunther, I; Humm, JL; Larson, SM; McCarthy, T; Morris, M; Pentlow, K; Scher, H; Squire, O; Welch, M	1
Alavi, A; Kumar, R; Zhuang, H	1
Larson, SM; Schöder, H	1
Berián, JM; Richter, JA; Rioja, J; Sanz, G; Zudaire, JJ	1
Rosenberg, RJ; Solis, V; Spencer, RP	1
Cook, G; Fogelman, I; Israel, O; Van der Wall, H	1
Akhurst, T; Chu, E; Ditullio, M; Heller, G; Kelly, WK; Larson, SM; Morris, MJ; Scher, HI; Schwartz, L; Siedlecki, K; Slovin, S; Verbel, D	1
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S	1
Chen, D; Cui, QC; Daniel, KG; Dou, QP; Liu, J; Orlu, S; Peng, F	1
Eberhard, S; Gönen, M; Herrmann, K; Hricak, H; Larson, SM; Scardino, P; Scher, HI; Schöder, H	1
Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB	1
Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS	1
Fogelman, I; Heinisch, M; Langsteger, W	1
Campa, J; Finn, R; Forster, G; Humm, J; Larson, S; Ling, C; Polycarpe-Holman, D; Zanzonico, P	1
Backhaus, B; Biersack, HJ; Jaeger, U; Matthies, A; Müller, SC; Palmedo, H; Reinhardt, M; von Mallek, D	1
Akino, H; Aoki, Y; Fujibayashi, Y; Kaneda, T; Matsuta, Y; Miwa, Y; Nakai, M; Okazawa, H; Oyama, N; Shioyama, R; Tanase, K; Yokoyama, O; Yonekura, Y	1
Bansal, A; DeGrado, TR; Hara, T	1
Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R	1
Ruibal, A; Sánchez-Salmón, A	1
Adam, MJ; Adomat, H; Dragowska, WH; Fadzli, L; Fazli, L; Gleave, M; Green, D; Kartono, A; Koch, CJ; Oliver, T; Ruth, T; Skov, KA; Sy, J; Woo, J; Yapp, DT	1
Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Hortling, N; Joe, AY; Palmedo, H	1
Albrecht, S; Buchegger, F; Hany, TF; Husarik, D; Khan, H; Miralbell, R; Soloviev, D; Vees, H; Zaidi, H	1
Bourguet, P; Montravers, F; Planchamp, F; Vincendeau, S	1
Balogova, S; Cussenot, O; Gattegno, B; Grahek, D; Gutman, F; Huchet, V; Kerrou, K; Kerrouche, N; Montravers, F; Talbot, JN; Thibault, P	1
Inoue, Y; Iwasaki, H; Nakatsuka, S; Soma, T; Tamaki, H; Yamagami, T	1
Henderson, R; Ho, L; Quan, V; Seto, J	1
Bouchelouche, K; Oehr, P	2
Grohé, C; Ko, Y; Palmedo, H; Tasci, S	1
Cavalcanti, JL; Macapinlac, HA; Mehran, RJ; Núñez, RF; Yeung, HW	1
Inoue, T; Lee, J; Shizukuishi, K; Takahashi, N; Yamaguchi, T	1
Chatziioannou, AF; Feeley, BT; Hsu, WK; Lieberman, JR; Stout, DB; Virk, MS	1
Abbruzzese, JL; Barron, BJ; Gould, KL; Herbst, RS; Mullani, NA; O'Neil, RG	1
Harisinghani, MG; John, SS; Shipley, WU; Zietman, AL	1
Katz, JK; Sharma, R	1
Altmann, A; Bellemann, ME; Blatter, J; Haberkorn, U; Kahn, B; Morr, I; Oberdorfer, F; van Kaick, G	1
Gross, MD; Grossman, HB; Shreve, PD; Wahl, RL	1
Finn, RD; Garza, D; Goldsmith, SJ; Horowitz, SM; Imbriaco, M; Kalaigian, H; Larson, SM; Reddy, D; Scher, HI; Yeh, SD; Zhang, JJ	1
Ide, M; Shohtsu, A; Takagi, S; Yasuda, S	1
Altmann, A; Berger, MR; Haag, D; Haberkorn, U; Oberdorfer, F; Peschke, P; Trojan, H; van Kaick, G; Ziegler, SI	1
Altmann, A; Bellemann, ME; Blatter, J; Brix, G; Doll, J; Gerlach, L; Haberkorn, U; Morr, I; Oberdorfer, F; van Kaick, G	1
Fisher, S; Grossman, HB; Kison, PV; Kosuda, S; Wahl, RL	1
Hara, T; Kishi, H; Kosaka, N	1
Akino, H; Kanamaru, H; Okada, K; Oyama, N	2
Endo, K; Inoue, T; Masuda, H; Oriuchi, N; Shimizu, N; Yamanaka, H	1
Block, T; Breul, J; Hartung, R; Hofer, C; Laubenbacher, C; Schwaiger, M	1
Nishimura, A; Ohira, S; Shinohara, M; Tomita, M	1
Macapinlac, H; Nunez, RF; Yeung, HW	1
Arocena, J; Berián, JM; Giménez, M; Richter, JA; Robles, JE; Rodriguez-Rubio, F; Rosell, D; Sánchez, D; Sanz, G	1
Akino, H; Kanamaru, H; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yonekura, Y	1
Amols, H; Fuks, Z; Humm, J; Koutcher, JA; Larson, S; Leibel, S; Ling, CC	1
Inoue, T; Koyama, K; Shimizu, N	1
Lai, YH; Liu, IJ; Segall, GM; Terris, MK; Zafar, MB	1
Baldwin, SW; Coleman, RE; DeGrado, TR; Orr, MD; Polascik, TJ; Price, DT; Robertson, CN; Wang, S	1
Ackermann, R; Börner, AR; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Müller-Mattheis, V	1
Akino, H; Ishida, H; Kanamaru, H; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Tanase, K; Yonekura, Y	1
Avril, N; Breul, J; Hartung, R; Hofer, C; Kübler, H	1
Akhurst, T; Coakley, F; Gonen, M; Hricak, H; Humm, J; Kelly, W; Larson, SM; Leibel, S; Macapinlac, HA; Scardino, P; Scher, H; Turlakow, A	1
Akhurst, T; Cai, S; Gonen, M; Larson, SM; Macapinlac, HA; Nuñez, R; Osman, I; Riedel, E; Scher, HI; Yeung, HW	1
Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y	1
Akhurst, T; Larson, SM; Macapinlac, H; Morris, MJ; Nunez, R; Osman, I; Scher, HI; Schwartz, L; Siedlecki, K; Verbel, D	1
Coleman, RE; DeGrado, TR; Liao, RP; Polascik, TJ; Price, DT; Robertson, CN	1

Reviews

70 review(s) available for fluorodeoxyglucose f18 and Cancer of Prostate

Article	Year
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more? Current opinion in urology, 2022, 05-01, Volume: 32, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostatic Neoplasms	2022
Recent topics of the clinical utility of PET/MRI in oncology and neuroscience. Annals of nuclear medicine, 2022, Volume: 36, Issue:9 Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms	2022
PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies. European radiology, 2023, Volume: 33, Issue:9 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Ligands; Male; Molecular Imaging; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Somatostatin	2023
The use of positron emission tomography imaging to guide radiation therapy. Clinical advances in hematology & oncology : H&O, 2023, Volume: 21, Issue:10 Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2023
Multimodality Imaging of Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:10 Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiparametric Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Theranostic Nanomedicine; Tomography, X-Ray Computed; Whole Body Imaging	2019
Benefits of positron emission tomography scans for the evaluation of radiotherapy. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:5 Topics: Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms	2020
PET imaging in urology: a rapidly growing successful collaboration. Current opinion in urology, 2020, Volume: 30, Issue:5 Topics: Antigens, Surface; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urology	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Prostate-specific Membrane Antigen PET in Prostate Cancer. Radiology, 2021, Volume: 299, Issue:2 Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals	2021
Imaging of a Pelvic Textiloma Using Clinical genitourinary cancer, 2017, Volume: 15, Issue:5 Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Foreign Bodies; Humans; Male; Pelvis; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2017
Novel imaging in advanced prostate cancer. Current opinion in supportive and palliative care, 2017, Volume: 11, Issue:3 Topics: Antigens, Surface; Choline Kinase; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Grading; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Sodium Fluoride	2017
PSMA ligands in prostate cancer - Probe optimization and theranostic applications. Methods (San Diego, Calif.), 2017, 11-01, Volume: 130 Topics: Animals; Antigens, Surface; Binding Sites; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Ligands; Male; Prostatic Neoplasms; Radioisotopes; Theranostic Nanomedicine	2017
Positron-emission tomography imaging in urological oncology: Current aspects and developments. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:11 Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Medical Oncology; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms	2018
Prostate cancer PET tracers: essentials for the urologist. The Canadian journal of urology, 2018, Volume: 25, Issue:4 Topics: Antigens, Surface; Carbon Radioisotopes; Carboxylic Acids; Cyclobutanes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Radiopharmaceuticals; Sodium Fluoride	2018
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT ( Journal of nuclear medicine technology, 2019, Volume: 47, Issue:1 Topics: Adenocarcinoma; Aged; Cell Transformation, Neoplastic; Clinical Decision-Making; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioactive Tracers; Treatment Outcome	2019
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics, 2018, Volume: 13, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pain; Patient Care Planning; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium	2018
Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40 Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2013
Imaging appearance of sarcomas of the prostate. Cancer imaging : the official publication of the International Cancer Imaging Society, 2013, May-30, Volume: 13 Topics: Adenocarcinoma; Bone Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed	2013
Update on positron emission tomography for imaging of prostate cancer. International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:1 Topics: Acetates; Carbon; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2014
[State of the art in nuclear imaging for the diagnosis of bone metastases]. Bulletin du cancer, 2013, Volume: 100, Issue:11 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Thyroid Neoplasms	2013
[Why is PET/CT essential in urooncology?]. Magyar onkologia, 2013, Volume: 57, Issue:4 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms	2013
Spectrum of the prostate lesions with increased FDG uptake on (18)F-FDG PET/CT. Abdominal imaging, 2014, Volume: 39, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
[Molecular multimodal hybrid imaging in prostate and bladder cancer]. Der Urologe. Ausg. A, 2014, Volume: 53, Issue:4 Topics: Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Molecular Imaging; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Penile metastases from bladder and prostate cancer detected by PET/CT: a report of 3 cases and a review of literature. Clinical genitourinary cancer, 2014, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Penile Neoplasms; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2014
Incidental uptake of 18F-fluorodeoxyglucose in the prostate gland. Systematic review and meta-analysis on prevalence and risk of malignancy. Nuklearmedizin. Nuclear medicine, 2014, Volume: 53, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Male; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity	2014
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:5-6 Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy	2014
[New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI]. Magyar onkologia, 2015, Volume: 59, Issue:1 Topics: Abdominal Neoplasms; Disease Management; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Medical Oncology; Multimodal Imaging; Neoplasms; Ovarian Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Thoracic Neoplasms	2015
Prognostic Utility of PET in Prostate Cancer. PET clinics, 2015, Volume: 10, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Multimodal Imaging; Nomograms; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
FDG in Urologic Malignancies. PET clinics, 2014, Volume: 9, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urologic Neoplasms	2014
Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer. Abdominal radiology (New York), 2016, Volume: 41, Issue:5 Topics: Acetates; Carbon; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals	2016
Influence of Four Radiotracers in PET/CT on Diagnostic Accuracy for Prostate Cancer: A Bivariate Random-Effects Meta-Analysis. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 39, Issue:2 Topics: Acetates; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; ROC Curve	2016
PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:Suppl 3 Topics: Biomarkers, Tumor; Cell Proliferation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Molecular Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2016
PET imaging for lymph node dissection in prostate cancer. World journal of urology, 2017, Volume: 35, Issue:4 Topics: Acetates; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals	2017
Is There Use for FDG-PET in Prostate Cancer? Seminars in nuclear medicine, 2016, Volume: 46, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Treatment Outcome	2016
PET Tracers Beyond FDG in Prostate Cancer. Seminars in nuclear medicine, 2016, Volume: 46, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Recurrence	2016
Imaging of Prostate Cancer Using Gallium-68-Labeled Bombesin. PET clinics, 2017, Volume: 12, Issue:2 Topics: Antigens, Surface; Bombesin; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorodeoxyglucose F18; Forecasting; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Bombesin	2017
Molecular imaging of prostate cancer. Methods (San Diego, Calif.), 2009, Volume: 48, Issue:2 Topics: Animals; Antigens, Neoplasm; Bombesin; Cell Line, Tumor; Choline; Dideoxynucleosides; Dihydrotestosterone; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Male; Membrane Glycoproteins; Molecular Diagnostic Techniques; Neoplasm Proteins; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2009
Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET. Nature reviews. Urology, 2009, Volume: 6, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms	2009
Emerging apoptosis agonists for bladder cancer. Expert opinion on emerging drugs, 2009, Volume: 14, Issue:4 Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms	2009
Imaging metastatic bone disease from carcinoma of the prostate. British journal of cancer, 2009, Oct-20, Volume: 101, Issue:8 Topics: Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2009
The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers. International journal of urology : official journal of the Japanese Urological Association, 2010, Volume: 17, Issue:6 Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urologic Neoplasms	2010
Assessing extracranial tumors using diffusion-weighted whole-body MRI. Zeitschrift fur medizinische Physik, 2011, Volume: 21, Issue:2 Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2011
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:1 Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2011
Positron emission tomography for benign and malignant disease. The Surgical clinics of North America, 2011, Volume: 91, Issue:1 Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed	2011
Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities. Clinical oncology (Royal College of Radiologists (Great Britain)), 2011, Volume: 23, Issue:9 Topics: Absorptiometry, Photon; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2011
[PET, PET-CT]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 5 Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2011
Functional MRI for radiotherapy dose painting. Magnetic resonance imaging, 2012, Volume: 30, Issue:9 Topics: Breast Neoplasms; Diagnostic Imaging; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Microcirculation; Neoplasms; Oxygen; Positron-Emission Tomography; Prostatic Neoplasms; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Reproducibility of Results	2012
Molecular imaging of prostate cancer: PET radiotracers. AJR. American journal of roentgenology, 2012, Volume: 199, Issue:2 Topics: Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Molecular Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity	2012
Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2002, Volume: 46, Issue:2 Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2002
PET-imaging in tumors of the reproductive trac. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2002, Volume: 46, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms	2002
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers]. Bulletin du cancer, 2003, Volume: 90 Spec No Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urologic Neoplasms	2003
Diagnosis of occult bone metastases: positron emission tomography. Clinical orthopaedics and related research, 2003, Issue:415 Suppl Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2003
PET in the management of urologic malignancies. Radiologic clinics of North America, 2004, Volume: 42, Issue:6 Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urogenital Neoplasms	2004
Positron emission tomography for prostate, bladder, and renal cancer. Seminars in nuclear medicine, 2004, Volume: 34, Issue:4 Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Treatment Outcome; Urinary Bladder Neoplasms	2004
PET and prostate cancer. World journal of urology, 2004, Volume: 22, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2004
Positron emission tomography and bone metastases. Seminars in nuclear medicine, 2005, Volume: 35, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2005
Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis. Frontiers in bioscience : a journal and virtual library, 2005, Sep-01, Volume: 10 Topics: Animals; Apoptosis; Copper; Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Pyrrolidines; Thiocarbamates; Tumor Cells, Cultured	2005
Positron emission tomography for radiation treatment planning. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2005, Volume: 181, Issue:8 Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms	2005
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Seminars in nuclear medicine, 2006, Volume: 36, Issue:1 Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2006
[Current value of positron emission tomography for prostate cancer follow-up]. Archivos espanoles de urologia, 2006, Volume: 59, Issue:10 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2006
[Clinical usefulness of positron emission tomography in prostate cancer]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 2 Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2007
Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. The Journal of urology, 2008, Volume: 179, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2008
PET and PET/CT with F-18 fluoride in bone metastases. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2008, Volume: 170 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
The roles of PET and PET/CT in the diagnosis and management of prostate cancer. Oncology, 2007, Volume: 72, Issue:3-4 Topics: Bone Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Neoplasms; Radioimmunodetection; Radiopharmaceuticals; Tomography, Emission-Computed	2007
Recent developments in urologic oncology: positron emission tomography molecular imaging. Current opinion in oncology, 2008, Volume: 20, Issue:3 Topics: Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm, Residual; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms	2008
Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases. International journal of radiation oncology, biology, physics, 2008, Volume: 71, Issue:1 Suppl Topics: Cell Hypoxia; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nanoparticles; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
[Fluorodeoxyglucose positron emission tomography in diagnosis of untreated prostate cancer]. Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Tomography, Emission-Computed	1998
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. International journal of radiation oncology, biology, physics, 2000, Jun-01, Volume: 47, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neoplasms; Prostatic Neoplasms; Radiobiology; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, Emission-Computed	2000
[Evaluation of prostate cancer with FDG PET study after therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58 Suppl Topics: Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Tomography, Emission-Computed	2000
Diagnosis and monitoring of urological tumors using positron emission tomography. European urology, 2001, Volume: 40, Issue:5 Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms	2001

Trials

24 trial(s) available for fluorodeoxyglucose f18 and Cancer of Prostate

Article	Year
Intra-individual comparison of The Lancet. Oncology, 2022, Volume: 23, Issue:12 Topics: Bone Neoplasms; Breast Neoplasms; Canada; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon	2022
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma. PloS one, 2022, Volume: 17, Issue:11 Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Urea	2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8 Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Orchiectomy; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Survival Analysis; Tomography, X-Ray Computed; Treatment Failure	2013
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma. European radiology, 2014, Volume: 24, Issue:3 Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Interventional	2014
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study). Molecular imaging and biology, 2015, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:2 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Prostatic Neoplasms; Registries; Sodium Fluoride; Treatment Outcome	2015
(11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET. Annals of nuclear medicine, 2016, Volume: 30, Issue:8 Topics: Aged; beta-Alanine; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms	2016
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:1 Topics: Acetylation; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Indoles; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Panobinostat; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome	2010
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. Journal of magnetic resonance imaging : JMRI, 2010, Volume: 31, Issue:5 Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome	2010
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Investigational new drugs, 2011, Volume: 29, Issue:6 Topics: 2-Methoxyestradiol; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Estradiol; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nanoparticles; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Treatment Outcome	2011
The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level. Annals of nuclear medicine, 2011, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed	2011
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Dec-15, Volume: 16, Issue:24 Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Survival Analysis; Technetium Tc 99m Medronate	2010
¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear medicine communications, 2011, Volume: 32, Issue:3 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Reference Standards; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2011
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy. Clinical nuclear medicine, 2011, Volume: 36, Issue:3 Topics: Acetates; Bone Neoplasms; Carbon; Docetaxel; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Treatment Outcome	2011
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Diarrhea; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult	2012
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Clinical nuclear medicine, 2012, Volume: 37, Issue:7 Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging	2012
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2002, Volume: 46, Issue:2 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Cervical Vertebrae; Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Lumbar Vertebrae; Male; Pelvis; Phantoms, Imaging; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Ribs; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed	2002
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:4 Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	2003
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:4 Topics: Acetates; Adenocarcinoma; Aged; Carbon; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed	2003
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:3 Topics: Aged; Bone Neoplasms; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting	2004
Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nuclear medicine and biology, 1996, Volume: 23, Issue:6 Topics: Aged; Androgens; Bone Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Technetium Tc 99m Medronate; Tomography, Emission-Computed	1996
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. European urology, 1999, Volume: 36, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Cicatrix; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	1999
11C-acetate PET imaging of prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:2 Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002

Other Studies

244 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Prostate

Article	Year
Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach. Medicina (Kaunas, Lithuania), 2021, Sep-17, Volume: 57, Issue:9 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2021
PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases. Clinical nuclear medicine, 2022, May-01, Volume: 47, Issue:5 Topics: Carcinoma, Adenoid Cystic; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2022
Stereotactic Radiotherapy for Lesions Detected via European urology oncology, 2022, Volume: 5, Issue:4 Topics: Androgen Antagonists; Androgens; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiosurgery	2022
18 F-FDG PET/CT Findings in a Patient With Primary Prostatic Synovial Sarcoma Combined With Adrenocortical Carcinoma. Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8 Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Adult; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Sarcoma, Synovial	2022
The differential diagnostic value of dual-phase Prostate cancer and prostatic diseases, 2022, Volume: 25, Issue:2 Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies	2022
Prostate-Specific Membrane Antigen-Avid Bone Metastases From Urothelial Carcinoma of the Bladder. Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10 Topics: Bone Neoplasms; Carcinoma, Transitional Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms	2022
68 Ga-PSMA-11 and 18 F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate. Clinical nuclear medicine, 2022, Sep-01, Volume: 47, Issue:9 Topics: Adenocarcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms	2022
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via European urology oncology, 2022, Volume: 5, Issue:4 Topics: Androgen Antagonists; Androgens; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms	2022
FDG PET/CT in Prostate Metastasis From Gastric Cancer. Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10 Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms	2022
Unusual Metastatic Prostate Cancer in Subcarinal Lymph Node and Peritoneal Nodule Found on 18 F-PSMA PET/CT With Rising PSA of 0.4 ng/mL. Clinical nuclear medicine, 2022, 11-01, Volume: 47, Issue:11 Topics: Aged; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Testosterone	2022
Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination. Clinical nuclear medicine, 2022, Jul-01, Volume: 47, Issue:7 Topics: Ad26COVS1; Choline; Cohort Studies; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Vaccination	2022
Reply to Ozan Cem Guler and Cem Onal's Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via European urology oncology, 2022, Volume: 5, Issue:4 Topics: Androgen Antagonists; Androgens; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Multimodal Imaging; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms	2022
FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prostate. Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Prostatic Neoplasms	2022
Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study. International journal of radiation oncology, biology, physics, 2022, 11-15, Volume: 114, Issue:4 Topics: Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prevalence; Prostatic Neoplasms	2022
68 Ga-FAPI PET/CT Detected Non-PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer. Clinical nuclear medicine, 2022, Dec-01, Volume: 47, Issue:12 Topics: Aged; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2022
Prostate Cancer Presenting as a Solitary Sacral Osteolytic Metastasis Mimicking Chordoma on Urology, 2022, Volume: 170 Topics: Chordoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2022
18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of Biochemically Recurrent Prostatic Adenocarcinoma. Clinical nuclear medicine, 2022, Dec-01, Volume: 47, Issue:12 Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Solitary Pulmonary Nodule	2022
Altered Glucose Metabolism Postchemotherapy Precedes PSMA Expression in Poorly Differentiated Prostate Cancer. Clinical nuclear medicine, 2023, Jan-01, Volume: 48, Issue:1 Topics: Aged; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glucose; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms	2023
Evaluation in Terms of Dosimetry and Fertility of F18-FDG and Ga68- PSMA in Prostate Cancer Imaging: A Simulation with GATE. Current radiopharmaceuticals, 2023, Volume: 16, Issue:2 Topics: Fertility; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals	2023
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa. Clinical nuclear medicine, 2023, Jan-01, Volume: 48, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Uterus	2023
Gene's expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study. Journal of translational medicine, 2023, 01-04, Volume: 21, Issue:1 Topics: Fluorodeoxyglucose F18; Glucose; Humans; Machine Learning; Male; Positron-Emission Tomography; Prostate; Prostatic Neoplasms	2023
[ European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:7 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iliac Vein; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Thrombosis; Vena Cava, Inferior	2023
Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer. Medicine, 2023, Jan-13, Volume: 102, Issue:2 Topics: Diuresis; Diuretics; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2023
68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer. Clinical nuclear medicine, 2023, Mar-01, Volume: 48, Issue:3 Topics: Aged; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2023
Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts. European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:6 Topics: Fluorodeoxyglucose F18; Glioma; Humans; Machine Learning; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Retrospective Studies	2023
The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings. Nuclear medicine communications, 2023, Apr-01, Volume: 44, Issue:4 Topics: Claudin-1; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms	2023
FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level. Clinical nuclear medicine, 2023, Jul-01, Volume: 48, Issue:7 Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals	2023
Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Carcinoma, Acinar Cell; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals	2023
Challenges in diagnosis and therapeutic options for metastatic prostate cancer to the right ventricle. BMJ case reports, 2023, Jun-23, Volume: 16, Issue:6 Topics: Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2023
Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CT. Nuclear medicine communications, 2023, Oct-01, Volume: 44, Issue:10 Topics: Carcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostatic Neoplasms	2023
Differentiation of Discordant Lesions on Dual-Tracer PET/CT ( Journal of nuclear medicine technology, 2023, Dec-05, Volume: 51, Issue:4 Topics: Carcinoma, Hepatocellular; Cell Differentiation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms	2023
68 Ga-PSMA-Avid Liver Metastases From Colon Cancer, Not Visualized on FDG PET Scan. Clinical nuclear medicine, 2023, 11-01, Volume: 48, Issue:11 Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms	2023
Comparison of 68Ga-PSMA-HBED-CC and 18F-FDG PET/CT in the Evaluation of Adenoid Cystic Carcinoma-A Prospective Study. Clinical nuclear medicine, 2023, Nov-01, Volume: 48, Issue:11 Topics: Adult; Carcinoma, Adenoid Cystic; Edetic Acid; Endothelial Cells; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Tomography, X-Ray Computed	2023
Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence. Clinical nuclear medicine, 2020, Volume: 45, Issue:1 Topics: Adenocarcinoma of Lung; Aged; Biological Transport; Carboxylic Acids; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence	2020
The Great Mimicker-Tuberculosis Involving Prostate and Vertebrae Posing as Metastatic Prostate Carcinoma on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:3 Topics: Aged; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Spine; Tuberculosis	2020
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:6 Topics: Animals; Antigens, Surface; Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Glutamate Carboxypeptidase II; Hexokinase; Humans; Male; Neoplasm Grading; Prostatic Neoplasms; Zebrafish	2020
Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[ Molecular imaging and biology, 2020, Volume: 22, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2020
Response to: Letter to the Editors: Re: Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[ Molecular imaging and biology, 2020, Volume: 22, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2020
99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence? Clinical nuclear medicine, 2020, Volume: 45, Issue:3 Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Organotechnetium Compounds; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography	2020
FDG Hepatic Superscan Due to Metastatic Infiltration of Prostate Cancer. Clinical nuclear medicine, 2020, Volume: 45, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2020
Urinary Reflux Into the Prostate Gland and Seminal Vesicles: A Potential Pitfall in 18F-FDG and 68Ga-PSMA PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:7 Topics: Artifacts; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Membrane Glycoproteins; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Seminal Vesicles; Urine	2020
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:9 Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prostatic Neoplasms; Urea	2020
Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1- NMR in biomedicine, 2020, Volume: 33, Issue:10 Topics: Animals; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Lactates; Male; Mice, Inbred BALB C; Positron-Emission Tomography; Prostatic Neoplasms; Pyruvic Acid; Tissue Distribution; Xenograft Model Antitumor Assays	2020
Clinical Evaluation of (4S)-4-(3-[ Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 10-15, Volume: 26, Issue:20 Topics: Aged; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tissue Distribution	2020
Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer? Nuclear medicine communications, 2020, Volume: 41, Issue:11 Topics: Aged; Bone and Bones; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Risk	2020
Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning. BMJ case reports, 2020, Sep-10, Volume: 13, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Robotic Surgical Procedures; Soft Tissue Neoplasms	2020
Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology. Prostate cancer and prostatic diseases, 2021, Volume: 24, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Niacinamide; Oligopeptides; Positron Emission Tomography Computed Tomography; Prognosis; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies	2021
18F-FDG PET/CT Imaging of Prostate Stromal Tumor of Uncertain Malignant Potential. Clinical nuclear medicine, 2021, 04-01, Volume: 46, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2021
Overlooked potential of positrons in cancer therapy. Scientific reports, 2021, 01-28, Volume: 11, Issue:1 Topics: Beta Particles; Cell Line, Tumor; Electrons; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiation Dosage; Radiopharmaceuticals	2021
Penile secondary lesions: a rare entity detected by PET/CT. Scientific reports, 2021, 03-15, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2021
The "Ultimate Triple PET": 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Aged; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radionuclide Imaging	2022
Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma. Clinical nuclear medicine, 2022, Mar-01, Volume: 47, Issue:3 Topics: Aged; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms	2022
Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative. Journal of medical imaging and radiation oncology, 2017, Volume: 61, Issue:4 Topics: Aged; Biomarkers, Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals	2017
Early Response Monitoring Following Radiation Therapy by Using [ Molecules (Basel, Switzerland), 2017, Nov-10, Volume: 22, Issue:11 Topics: Acetates; Animals; Blotting, Western; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Reproducibility of Results; Xenograft Model Antitumor Assays	2017
Incidental Detection of Metastatic Malignant Melanoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT Imaging: Correlative Imaging With FDG PET/CT and Review of the Literature. Clinical nuclear medicine, 2018, Volume: 43, Issue:3 Topics: Aged, 80 and over; Biopsy, Fine-Needle; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Incidental Findings; Male; Melanoma; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence	2018
Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:4 Topics: Adenocarcinoma; Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neuroendocrine Tumors; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2018
Increased Prostate Cancer Glucose Metabolism Detected by European urology focus, 2019, Volume: 5, Issue:6 Topics: Aged; Case-Control Studies; Disease-Free Survival; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Risk Assessment; Severity of Illness Index	2019
Prostate-Specific Membrane Antigen-Negative Metastases-A Potential Pitfall in Prostate-Specific Membrane Antigen PET. Clinical nuclear medicine, 2018, Volume: 43, Issue:6 Topics: Adult; Diagnosis, Differential; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Histiocytoma; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2018
Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer. Clinical nuclear medicine, 2018, Volume: 43, Issue:7 Topics: Adenocarcinoma; Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2018
Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy? Urology journal, 2018, 09-26, Volume: 15, Issue:5 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Technetium Tc 99m Medronate	2018
The Utility of [ Molecular imaging and biology, 2018, Volume: 20, Issue:6 Topics: Animals; Cell Line, Tumor; Diazonium Compounds; Female; Fluorodeoxyglucose F18; Glycolysis; Heterografts; Humans; Male; Mice; Mice, Nude; Molecular Imaging; Neoplasm Transplantation; PC-3 Cells; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Neoplasms; Sulfanilic Acids	2018
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. Acta medica Okayama, 2018, Volume: 72, Issue:3 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2018
18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2018
18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor. Clinical nuclear medicine, 2019, Volume: 44, Issue:1 Topics: Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2019
Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceedings of the National Academy of Sciences of the United States of America, 2018, 11-06, Volume: 115, Issue:45 Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Coordination Complexes; Dendrimers; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms	2018
18F-FDG PET/CT Imaging in an Adolescent Patient With Primary Prostatic Stromal Sarcoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:1 Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma	2019
Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases. Clinical nuclear medicine, 2019, Volume: 44, Issue:1 Topics: Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2019
A prospective study on dual time BMC research notes, 2018, Dec-07, Volume: 11, Issue:1 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Care; Prospective Studies; Prostatic Neoplasms; Risk Factors; Time Factors	2018
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report. Medicine, 2019, Volume: 98, Issue:11 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine	2019
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay. Mutagenesis, 2019, 09-20, Volume: 34, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cell-Free Nucleic Acids; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Liquid Biopsy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Time Factors; Young Adult	2019
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans. Clinical nuclear medicine, 2019, Volume: 44, Issue:10 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lysine; Male; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea	2019
Antilipolytic drug boosts glucose metabolism in prostate cancer. Nuclear medicine and biology, 2013, Volume: 40, Issue:4 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Male; Mice; Mice, Nude; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazines; Tissue Distribution	2013
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT. Abdominal imaging, 2013, Volume: 38, Issue:5 Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Sciatic Nerve; Tomography, X-Ray Computed; Vascular Neoplasms	2013
Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:6 Topics: Animals; Biological Transport; Dehydroascorbic Acid; Disease Models, Animal; Fluorodeoxyglucose F18; Magnetic Resonance Spectroscopy; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms	2013
Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT. Clinical nuclear medicine, 2014, Volume: 39, Issue:7 Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2014
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Molecular imaging and biology, 2014, Volume: 16, Issue:3 Topics: Animals; Carboxylic Acids; Cell Line, Tumor; Cyclobutanes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hydrogen-Ion Concentration; Inflammation; Male; Methionine; Prostatic Neoplasms; Rats	2014
Positron emission tomography/computerized tomography in the evaluation of primary non-Hodgkin's lymphoma of prostate. World journal of gastroenterology, 2013, Oct-21, Volume: 19, Issue:39 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate. Clinical nuclear medicine, 2014, Volume: 39, Issue:8 Topics: Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
MRI and FDG PET/CT findings of malignant fibrous histiocytoma of the prostate. Clinical nuclear medicine, 2014, Volume: 39, Issue:10 Topics: Adult; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Influence of free fatty acids on glucose uptake in prostate cancer cells. Nuclear medicine and biology, 2014, Volume: 41, Issue:3 Topics: Acetates; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Glucose; Humans; Male; Prostatic Neoplasms	2014
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology, 2014, Volume: 271, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cross-Sectional Studies; Diatrizoate; Diatrizoate Meglumine; Dihydrotestosterone; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed	2014
Incidental prostate ¹⁸F-FDG uptake without calcification indicates the possibility of prostate cancer. Oncology reports, 2014, Volume: 31, Issue:4 Topics: Aged; Aged, 80 and over; Calcinosis; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Japan; Male; Middle Aged; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies	2014
18F-FDG PET/CT superscan in prostate cancer. Clinical nuclear medicine, 2014, Volume: 39, Issue:10 Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:4 Topics: Aged; Aged, 80 and over; Cohort Studies; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Registries; Sodium Fluoride; Tomography, X-Ray Computed; United States	2014
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis. Annals of nuclear medicine, 2014, Volume: 28, Issue:5 Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Recurrence; Time Factors	2014
Re: Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images? The Journal of urology, 2014, Volume: 191, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Tomography, X-Ray Computed	2014
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine. Current cancer drug targets, 2014, Volume: 14, Issue:4 Topics: Affinity Labels; Animals; Biological Transport; Cell Line, Tumor; Choline; Coordination Complexes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Integrin alphaV; Integrin beta3; Integrins; Isotope Labeling; Male; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Oligopeptides; Peptides, Cyclic; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals	2014
Utility of FDG-PET in clinical neuroendocrine prostate cancer. The Prostate, 2014, Volume: 74, Issue:11 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prevalence; Prostatic Neoplasms; Retrospective Studies; Soft Tissue Neoplasms	2014
Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:11 Topics: Aged; Biological Transport; Choline; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Neoplasm Metastasis; Organ Specificity; Prostatic Neoplasms; Quality Control; Radionuclide Imaging; Retrospective Studies; Urinary Tract; Urography	2014
Malignant nonepithelial prostate tumors: FDG PET/CT findings with MRI and CT correlation. Clinical nuclear medicine, 2015, Volume: 40, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
AEG-1 promoter-mediated imaging of prostate cancer. Cancer research, 2014, Oct-15, Volume: 74, Issue:20 Topics: Animals; Bone Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases, Firefly; Male; Membrane Proteins; Mice, Inbred NOD; Mice, SCID; Molecular Diagnostic Techniques; Neoplasm Transplantation; Promoter Regions, Genetic; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; RNA-Binding Proteins; Transcriptional Activation	2014
Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:20 Topics: Aged; Aged, 80 and over; Cohort Studies; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiographic Image Enhancement; Republic of Korea; Retrospective Studies; Tomography, X-Ray Computed	2014
18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jan-15, Volume: 21, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nitroimidazoles; Oxadiazoles; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazoles; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays	2015
Resection of a solitary pulmonary metastasis from prostatic Adenocarcinoma misdiagnosed as a Bronchocele: usefulness of 18F-choline and 18F-FDG PET/CT. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:12 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2014
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells. Molecular imaging and biology, 2015, Volume: 17, Issue:3 Topics: Antineoplastic Agents; Cell Line, Tumor; Choline; Docetaxel; Drug Screening Assays, Antitumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Taxoids	2015
Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Molecular imaging and biology, 2015, Volume: 17, Issue:4 Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Epoxy Compounds; Fluorodeoxyglucose F18; Glucose; Heterografts; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Mice; Mice, Nude; Oxidation-Reduction; Positron-Emission Tomography; Prostatic Neoplasms	2015
Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups. Bioconjugate chemistry, 2015, Feb-18, Volume: 26, Issue:2 Topics: Animals; Bombesin; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Tissue Distribution	2015
Quantitative graphical analysis of simultaneous dynamic PET/MRI for assessment of prostate cancer. Clinical nuclear medicine, 2015, Volume: 40, Issue:4 Topics: Aged; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2015
[11C-choline PET/CT in the diagnosis of prostate cancer -- Hungarian experience]. Magyar onkologia, 2015, Volume: 59, Issue:1 Topics: Aged; Carbon Radioisotopes; Choline; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hungary; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2015
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. World journal of urology, 2015, Volume: 33, Issue:11 Topics: Aged; Choline; Combined Modality Therapy; Diagnosis, Differential; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed	2015
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:1 Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sensitivity and Specificity; Technetium Compounds	2016
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions. International journal of radiation oncology, biology, physics, 2015, Jun-01, Volume: 92, Issue:2 Topics: Adult; Aged; Analysis of Variance; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tumor Burden	2015
Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate. Korean journal of urology, 2015, Volume: 56, Issue:4 Topics: Adenocarcinoma; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Organ Specificity; Positron-Emission Tomography; Prevalence; Prostate; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Tissue Distribution	2015
FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy. Cancer imaging : the official publication of the International Cancer Imaging Society, 2015, Mar-03, Volume: 15 Topics: Adenocarcinoma; Aged; Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Nuclear medicine communications, 2015, Volume: 36, Issue:9 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed	2015
Beware of the "Bronchocele," Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article "Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015, Volume: 10, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms	2015
Reply to "18F-Choline PET-CT in the Management of Lung Cancer and Mucinous Tumors?". Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015, Volume: 10, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms	2015
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer. Clinical nuclear medicine, 2015, Volume: 40, Issue:8 Topics: Aged; Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome. Clinical nuclear medicine, 2015, Volume: 40, Issue:8 Topics: Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:7 Topics: Aged; Antigens, Surface; Biomarkers, Tumor; Biopsy; Cysteine; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Hypertrophy; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Multicentre study of 18F-FDG-PET/CT prostate incidental uptake. Japanese journal of radiology, 2015, Volume: 33, Issue:9 Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2015
Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance? Abdominal imaging, 2015, Volume: 40, Issue:8 Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2015
Primary Prostatic Extragastrointestinal Stromal Tumor on 18F-FDG PET/CT. Clinical nuclear medicine, 2016, Volume: 41, Issue:3 Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT. Clinical nuclear medicine, 2016, Volume: 41, Issue:1 Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, X-Ray Computed	2016
Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12 Topics: Adult; Aged; Bone and Bones; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Whole Body Imaging	2015
Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:3 Topics: Choline; Elasticity Imaging Techniques; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2016
18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate. Clinical nuclear medicine, 2016, Volume: 41, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer. Nuclear medicine communications, 2016, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Ammonia; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Prostatic Neoplasms; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging	2016
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation? The Journal of urology, 2016, Volume: 195, Issue:4 Pt 1 Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals	2016
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells. Scientific reports, 2015, Nov-30, Volume: 5 Topics: Aged; Aged, 80 and over; Animals; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Down-Regulation; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Hexokinase; Humans; Kallikreins; Ki-67 Antigen; Male; Mice; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; X-Ray Microtomography	2015
Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. Nuclear medicine communications, 2016, Volume: 37, Issue:4 Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms	2016
Prostate Lymphoma Complicated With Prostatorectal Fistula and Multifocal Infection After Chemotherapy. Clinical nuclear medicine, 2016, Volume: 41, Issue:3 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Fistula; Sepsis; Tomography, X-Ray Computed	2016
Impact and correction of the bladder uptake on 18 F-FCH PET quantification: a simulation study using the XCAT2 phantom. Physics in medicine and biology, 2016, Jan-21, Volume: 61, Issue:2 Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Male; Phantoms, Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urinary Bladder	2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy. Clinical nuclear medicine, 2016, Volume: 41, Issue:4 Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium; Tomography, X-Ray Computed; Tumor Burden	2016
Lung Metastasis From Prostate Cancer Revealed by 18F-FDG PET/CT Without Osseous Metastasis on Bone Scan. Clinical nuclear medicine, 2016, Volume: 41, Issue:5 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2016
Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2016
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
FDG PET/CT Imaging of Prostate Carcinosarcoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: Carcinoma, Squamous Cell; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transurethral Resection of Prostate; Urinary Retention	2016
FDG PET/CT in Peritoneal Metastasis From Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2016
Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal Therapy. The Prostate, 2016, Volume: 76, Issue:13 Topics: Animals; Fluorodeoxyglucose F18; Hot Temperature; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Nanoparticles; Phototherapy; Prostatic Neoplasms; Thermometry	2016
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies. Nuclear medicine and biology, 2016, Volume: 43, Issue:6 Topics: Biological Transport; Cell Line, Tumor; Choline; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lipopolysaccharides; Macrophages; Male; Positron-Emission Tomography; Prostatic Neoplasms	2016
Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Adenocarcinoma; Antigens, Surface; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate	2016
[Primary Squamous Cell Carcinoma of the Prostate in which Docetaxel Therapy was Effective : A Case Report]. Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:5 Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids	2016
Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:10 Topics: Adenocarcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2016
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series. Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Aug-31, Volume: 16, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms	2016
A rare case of rectal carcinoma and prostate carcinoma with coexistent Paget's disease mimicking bone metastases in both European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1 Topics: Aged; Bone Neoplasms; Diagnosis, Differential; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Oligopeptides; Osteitis Deformans; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rare Diseases; Rectal Neoplasms	2017
Letter to the Editor - Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:22 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2016
How we read FCH-PET/CT for prostate cancer. Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Dec-06, Volume: 16, Issue:1 Topics: Aged; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution	2016
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging. Journal of visualized experiments : JoVE, 2016, 12-30, Issue:118 Topics: Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Pyruvic Acid	2016
FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate. World journal of surgical oncology, 2008, Jun-19, Volume: 6 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Eosinophilic pneumonia and thoracic metastases as an initial manifestation of prostatic carcinoma. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:15 Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Pulmonary Eosinophilia; Thoracic Neoplasms	2008
Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone. Bone, 2009, Volume: 44, Issue:1 Topics: Acid Phosphatase; Animals; Bone Morphogenetic Proteins; Cell Line, Tumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hindlimb; Humans; Isoenzymes; Male; Mice; Mice, SCID; Neoplasm Transplantation; Osteolysis; Positron-Emission Tomography; Prostatic Neoplasms; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Tartrate-Resistant Acid Phosphatase; Tibia; Tomography, X-Ray Computed	2009
A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography. Clinical nuclear medicine, 2008, Volume: 33, Issue:11 Topics: Adenocarcinoma; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urinary Bladder Neoplasms; Whole Body Imaging	2008
[Positron emission tomography with 18-fluorine deoxyglucose in the diagnosis and assessment of prostate cancer]. Voprosy onkologii, 2008, Volume: 54, Issue:4 Topics: Aged; Chronic Disease; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis; Radiopharmaceuticals; Ultrasonography; Whole-Body Irradiation	2008
Positron-emission tomography in imaging and staging prostate cancer. Cancer biomarkers : section A of Disease markers, 2008, Volume: 4, Issue:4-5 Topics: Acetates; Aged; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Characterization of preclinical models of prostate cancer using PET-based molecular imaging. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:8 Topics: Animals; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Hormones; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Reproducibility of Results	2009
Detection of prostatic glandular adenocarcinoma during staging of non-small-cell lung carcinoma with F-18 FDG PET. Clinical nuclear medicine, 2009, Volume: 34, Issue:2 Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2009
Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer. Annals of nuclear medicine, 2009, Volume: 23, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2009
Nodal metastasis from occult thyroid cancer detected by FDG PET-CT in a patient with 2 known malignancies. Clinical nuclear medicine, 2009, Volume: 34, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prostatic Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed	2009
Avid F-18 FDG uptake in prostatic sarcoma. Clinical nuclear medicine, 2009, Volume: 34, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Radionuclide Imaging; Sarcoma; Whole Body Imaging	2009
Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment. Molecular imaging and biology, 2010, Volume: 12, Issue:2 Topics: Adult; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms	2010
Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: Aged; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2009
[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml]. Actas urologicas espanolas, 2009, Volume: 33, Issue:8 Topics: Adult; Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals	2009
Chylothorax due to metastatic prostate carcinoma: an unusual complication. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:11 Topics: Adenocarcinoma; Biopsy; Chylothorax; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome	2009
Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:1 Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2010
Interesting image. Extrapulmonary small cell carcinoma in prostate: detection with F-18 FDG PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:1 Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2010
Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer. Clinical nuclear medicine, 2009, Volume: 34, Issue:12 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach. Anticancer research, 2010, Volume: 30, Issue:2 Topics: Cell Survival; Cells, Cultured; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Palmitic Acids; Prostate; Prostatic Neoplasms; Radionuclide Imaging; Sweetening Agents	2010
Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma. International journal of clinical oncology, 2010, Volume: 15, Issue:6 Topics: Aged; Biomarkers, Tumor; Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; Male; Positron-Emission Tomography; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
FDG-PET/CT in evaluation and prognostication of primary prostate lymphoma. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Tomography, X-Ray Computed	2010
A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2010
F-18 FDG PET/CT imaging in small cell prostate cancer. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2010
Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer. Journal of medical imaging and radiation oncology, 2010, Volume: 54, Issue:4 Topics: Aged; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostate; Prostatic Neoplasms; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2010
Midline cyst of the prostate mimicking malignancy on FDG PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:10 Topics: Cysts; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2010
Incidental fleurodeoxyglucose uptake in the prostate. The British journal of radiology, 2010, Volume: 83, Issue:995 Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals	2010
Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. The British journal of radiology, 2010, Volume: 83, Issue:995 Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2010
[Tumor diagnosis with PET-CT. Are false hopes raised in cancer patients? (interview by Ute Kempf)]. MMW Fortschritte der Medizin, 2010, Oct-07, Volume: 152, Issue:40 Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insurance Coverage; Lung Neoplasms; Male; National Health Programs; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures	2010
Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion. Bone, 2011, Mar-01, Volume: 48, Issue:3 Topics: Animals; Bone Morphogenetic Proteins; Bone Neoplasms; Bone Resorption; Cell Line, Tumor; Fluorodeoxyglucose F18; Hindlimb; Humans; Male; Mice; Mice, SCID; Osteoclasts; Osteogenesis; Positron-Emission Tomography; Prostatic Neoplasms; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Recombinant Fusion Proteins; Signal Transduction; Tibia; Tumor Burden; X-Ray Microtomography	2011
Beyond FDG: Many Molecular Imaging Agents Are in Development. Journal of the National Cancer Institute, 2011, Jan-05, Volume: 103, Issue:1 Topics: Biomarkers, Tumor; Breast Neoplasms; Dihydrotestosterone; Drug Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Radiology; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Androgen; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies. The British journal of radiology, 2011, Volume: 84, Issue:999 Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Spinal Neoplasms; Spine; Tomography, X-Ray Computed; Urinary Bladder Neoplasms	2011
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:2 Topics: Aged; Analysis of Variance; Choline; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
FDG PET imaging in a patient with primary seminoma of the prostate. Clinical nuclear medicine, 2011, Volume: 36, Issue:7 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Seminoma; Tomography, X-Ray Computed	2011
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. Cancer research, 2011, Aug-01, Volume: 71, Issue:15 Topics: Adenocarcinoma; Astrocytoma; Breast Neoplasms; Cell Line, Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, myc; Glucose; Glycolysis; Humans; Male; Melanoma; Neoplasm Proteins; Positron-Emission Tomography; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Radiopharmaceuticals; RNA, Messenger; RNA, Neoplasm	2011
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines? European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:10 Topics: Acetates; Androgens; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Prostatic Neoplasms	2011
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:10 Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transplantation, Heterologous	2011
Simultaneous rectal schwannoma and prostatic adenocarcinoma detected on FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:10 Topics: Adenocarcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Prostatic Neoplasms; Rectal Neoplasms; Tomography, X-Ray Computed	2011
FDG PET/CT demonstration of pancreatic metastasis from prostate cancer. Clinical nuclear medicine, 2011, Volume: 36, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed	2011
The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2011, Volume: 15, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Colonic Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity	2011
Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:11 Topics: Automation; Biomarkers, Tumor; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Molecular Imaging; Multimodal Imaging; Orchiectomy; Positron-Emission Tomography; Prostatic Neoplasms; Reference Standards; Retrospective Studies; Tomography, X-Ray Computed	2011
Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT. Annals of nuclear medicine, 2012, Volume: 26, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:2 Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Recurrence; Time Factors; Tomography, X-Ray Computed	2012
Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Feb-15, Volume: 18, Issue:4 Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Deuterium; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Kidney; Kinetics; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers	2012
Q Fever masquerading as prostate cancer metastases. Clinical nuclear medicine, 2012, Volume: 37, Issue:5 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Q Fever; Radionuclide Imaging; Technetium Tc 99m Medronate; Whole Body Imaging	2012
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:4 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Choline; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunodetection; Radiopharmaceuticals	2012
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer epidemiology, 2012, Volume: 36, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms	2012
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT. Radiation oncology (London, England), 2012, Aug-08, Volume: 7 Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed	2012
Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images? Annals of nuclear medicine, 2013, Volume: 27, Issue:2 Topics: Biological Transport; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed	2013
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. AJR. American journal of roentgenology, 2012, Volume: 199, Issue:5 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Chi-Square Distribution; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2012
Prostate-specific antigen-negative prostate cancer recurrence? Urology, 2013, Volume: 81, Issue:2 Topics: Aged; Bone Neoplasms; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan. Japanese journal of radiology, 2013, Volume: 31, Issue:4 Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed	2013
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer. AJR. American journal of roentgenology, 2002, Volume: 179, Issue:2 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2002
CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography. The Journal of urology, 2002, Volume: 168, Issue:3 Topics: Acyclovir; Animals; Blotting, Western; Fluorodeoxyglucose F18; Genes, Reporter; Genetic Therapy; Genetic Vectors; Guanine; Herpesvirus 1, Human; Humans; Male; Mice; Mice, SCID; Neoplasm Transplantation; Prostatic Neoplasms; Radiopharmaceuticals; Thymidine Kinase; Tomography, Emission-Computed; Transfection; Tumor Cells, Cultured	2002
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:5 Topics: Adenocarcinoma; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Proteins; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	2002
MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model. Nuclear medicine and biology, 2002, Volume: 29, Issue:8 Topics: Acetates; Androgen Antagonists; Androgens; Animals; Carbon; Diethylstilbestrol; Dihydrotestosterone; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Tomography, Emission-Computed	2002
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging]. Der Urologe. Ausg. A, 2002, Volume: 41, Issue:6 Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	2002
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. The Journal of urology, 2003, Volume: 169, Issue:4 Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer. Urologia internationalis, 2003, Volume: 70, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	2003
New horizons in oncologic imaging. The New England journal of medicine, 2003, Jun-19, Volume: 348, Issue:25 Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetics; Male; Medical Oncology; Nanotechnology; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer. BJU international, 2003, Volume: 92, Issue:1 Topics: Abdominal Neoplasms; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pelvic Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2003
[18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report. The American surgeon, 2003, Volume: 69, Issue:7 Topics: Carcinoma; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Case report: PET scan detects prostate cancer in a patient with Hodgkins lymphoma. Annals of clinical and laboratory science, 2003,Summer, Volume: 33, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Middle Aged; Neoplasms, Multiple Primary; Prostatic Neoplasms; Tomography, Emission-Computed	2003
99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:12 Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed	2003
B cell lymphoma: a case with localized involvement of the prostate on F-18-FDG examination. Clinical nuclear medicine, 2005, Volume: 30, Issue:4 Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Prostatic Neoplasms; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Urinary Retention	2005
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-01, Volume: 11, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Microtubules; Neoplasm Metastasis; Orchiectomy; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome	2005
Dependence of FDG uptake on tumor microenvironment. International journal of radiation oncology, biology, physics, 2005, Jun-01, Volume: 62, Issue:2 Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals	2005
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-01, Volume: 11, Issue:13 Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity	2005
[Positron emission tomography in oncourology]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2005, Issue:9 Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis	2005
MRI better than FDG-PET at detecting liver tumors. Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:9 Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate	2005
Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors. Nuclear medicine and biology, 2006, Volume: 33, Issue:1 Topics: Animals; Carcinoma, Squamous Cell; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Male; Misonidazole; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results; Restraint, Physical; Sensitivity and Specificity; Species Specificity; Subtraction Technique	2006
[Technical limits of PET/CT with 18FDG in prostate cancer]. Aktuelle Urologie, 2006, Volume: 37, Issue:3 Topics: Adenocarcinoma; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed	2006
[Pet imaging in prostate cancer]. Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:6 Topics: Acetates; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2006
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells. Nuclear medicine and biology, 2006, Volume: 33, Issue:8 Topics: Acetates; Adenosine Triphosphate; Carbon Radioisotopes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Choline; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tritium	2006
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma]. Revista espanola de medicina nuclear, 2006, Volume: 25, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures	2006
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography. BJU international, 2007, Volume: 99, Issue:5 Topics: Androgen Antagonists; Androgens; Animals; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Hypoxia; Male; Mice; Oxygen; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity	2007
Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer. Prostate cancer and prostatic diseases, 2007, Volume: 10, Issue:3 Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Incidental Findings; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. BJU international, 2007, Volume: 99, Issue:6 Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome	2007
[2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2007, Volume: 17, Issue:2 Topics: Fluorodeoxyglucose F18; France; Humans; Image Processing, Computer-Assisted; Kidney Neoplasms; Male; Medical Laboratory Science; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Urinary Bladder Neoplasms	2007
False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma. European journal of haematology, 2007, Volume: 79, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prostatic Neoplasms; Rituximab; Vincristine	2007
High-grade urothelial carcinoma of the prostate on FDG PET-CT. Clinical nuclear medicine, 2007, Volume: 32, Issue:9 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Urologic Neoplasms; Urothelium	2007
Incidental finding of prostate cancer and adenomatous colon polyp in a patient with lung cancer. Clinical nuclear medicine, 2007, Volume: 32, Issue:11 Topics: Abdomen; Adenomatous Polyps; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Prostatic Neoplasms; Thorax; Tomography, X-Ray Computed	2007
Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:3 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, SCID; Osteolysis; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution	2008
Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Male; Oxygen Radioisotopes; Positron-Emission Tomography; Prostatic Neoplasms; Regional Blood Flow	2008
Taxotere chemosensitivity evaluation in mice prostate tumor: validation and diagnostic accuracy of quantitative measurement of tumor characteristics by MRI, PET, and histology of mice tumor. Technology in cancer research & treatment, 2008, Volume: 7, Issue:3 Topics: Animals; Antineoplastic Agents; Docetaxel; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Taxoids	2008
Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:11 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Deoxyglucose; Fluorodeoxyglucose F18; Gemcitabine; In Vitro Techniques; Male; Prostatic Neoplasms; Rats; Tomography, Emission-Computed; Tumor Cells, Cultured	1994
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology, 1996, Volume: 199, Issue:3 Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1996
[Cancer screening with whole-body FDG PET]. Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed	1996
FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nuclear medicine and biology, 1994, Volume: 21, Issue:6 Topics: Animals; Cell Division; Deoxyglucose; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Hexokinase; Male; Mammary Neoplasms, Experimental; Monosaccharide Transport Proteins; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tomography, Emission-Computed	1994
PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:8 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Deoxyglucose; DNA, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Male; Neoplasm Transplantation; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Ribonucleotide Reductases; Thymidine; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured	1997
Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Annals of nuclear medicine, 1997, Volume: 11, Issue:3 Topics: Adult; Aged; Animals; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Retrospective Studies; Testis; Tomography, Emission-Computed; Urinary Bladder; Urinary Bladder Neoplasms	1997
PET imaging of prostate cancer using carbon-11-choline. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1998
Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy. The Journal of urology, 1999, Volume: 161, Issue:2 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1999
[Evaluation of 18F-FDG positron emission tomography (PET) in the detection of unknown primary tumors]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1999, Volume: 74, Issue:3 Topics: Aged; Animals; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Increased F-18 FDG uptake in the stomach. Clinical nuclear medicine, 1999, Volume: 24, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Humans; Male; Prostatic Neoplasms; Radiopharmaceuticals; Stomach; Tomography, Emission-Computed; Whole-Body Counting	1999
Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer. BJU international, 1999, Volume: 84, Issue:9 Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1999
The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Japanese journal of clinical oncology, 1999, Volume: 29, Issue:12 Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology, 2001, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2001
[Evaluation of prostate cancer using FDG-PET]. Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:11 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2000
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer research, 2001, Jan-01, Volume: 61, Issue:1 Topics: Aged; Aged, 80 and over; Animals; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Isotope Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Prostatic Neoplasms; Quaternary Ammonium Compounds; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Pilot Projects; Proline; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2001
FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. Nuclear medicine communications, 2001, Volume: 22, Issue:9 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Fluorodeoxyglucose F18; Glucose; Goserelin; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, Emission-Computed	2001
Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:3 Topics: Aged; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	2001
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:1 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology, 2002, Volume: 59, Issue:6 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed	2002
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. The Journal of urology, 2002, Volume: 168, Issue:1 Topics: Animals; Choline; Fluorine Compounds; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured	2002